The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 76,192 | 71,424 | 64,977 | 60,921 | 55,161 |
| Cost of Goods | 62,093 | 55,795 | 51,977 | 49,779 | 42,839 |
| Gross Profit | 14,099 | 15,629 | 13,000 | 11,142 | 12,322 |
| Operating Expenses | 47,059 | 41,503 | 34,074 | 30,225 | 31,632 |
| Operating Income | -32,867 | -25,079 | -20,097 | -18,304 | -18,471 |
| Interest Expense | 1,443 | 2,450 | 1,497 | 61 | 74 |
| Other Income | 4,356 | 16,155 | 18,896 | 12,880 | 38,011 |
| Pre-tax Income | -29,954 | -11,374 | -2,698 | -5,485 | 19,466 |
| Income Tax | 44 | -367 | -24 | -32 | 180 |
| Net Income Continuous | -29,998 | -11,007 | -2,674 | -5,453 | 19,286 |
| Net Income | $-29,998 | $-11,007 | $-2,674 | $-5,453 | $19,286 |
| EPS Basic Total Ops | -0.33 | -0.13 | -0.03 | -0.06 | 0.22 |
| EPS Basic Continuous Ops | -0.41 | -0.15 | -0.04 | -0.07 | 0.26 |
| EPS Diluted Total Ops | -0.33 | -0.19 | -0.17 | -0.06 | 0.21 |
| EPS Diluted Continuous Ops | -0.41 | -0.14 | -0.03 | -0.07 | 0.25 |
| EBITDA(a) | $-14,128 | $-13,382 | $-18,100 | $-17,206 | $-17,484 |